Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunological Memory01:23

Immunological Memory

17.6K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
17.6K
Vaccinations01:51

Vaccinations

53.0K
Overview
53.0K
Active versus Passive Immunity01:31

Active versus Passive Immunity

11.7K
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
11.7K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.8K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

9.8K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
9.8K
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

3.9K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
3.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunological insights into why pertussis continues to be endemic.

Human vaccines & immunotherapeutics·2026
Same author

Core histopathology versus cytology in endoscopic ultrasound-guided fine-needle biopsy for solid pancreatic lesions.

Gastrointestinal endoscopy·2026
Same author

Association of duration of amino acids infusion and renal protection: is 48 hours of amino acids infusion enough after cardiac surgery? Comment on Br J Anaesth 2025.

British journal of anaesthesia·2026
Same author

Unpacking the Heterogeneity of Cyberchondria: Latent Profile Analysis of Cyberchondria and the Buffering Role of Trait Mindfulness.

Cyberpsychology, behavior and social networking·2026
Same author

Association of HLA class II haplotypes with antibody concentrations after diphtheria-tetanus acellular pertussis booster vaccination in four age groups of Finnish participants.

Vaccine·2026
Same author

Lactate-Induced Lipid Accumulation in Hepatocytes through GPR81 Activation (Diabetes Metab J 2026;50:307-19).

Diabetes & metabolism journal·2026

Related Experiment Video

Updated: Mar 9, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.4K

Immune persistence after pertussis vaccination.

Zhiyun Chen1, Qiushui He1,2

  • 1a Department of Medical Microbiology and Research Centre of Microbiome , Capital Medical University , Beijing , China.

Human Vaccines & Immunotherapeutics
|January 4, 2017
PubMed
Summary
This summary is machine-generated.

Pertussis (whooping cough) immunity wanes over time, especially after acellular vaccines. Booster shots or maternal immunization are crucial for sustained protection, particularly in older populations.

Keywords:
acellular pertussis vaccinesimmune persistencepertussisvaccinationwhole cell pertussis vaccines

More Related Videos

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

11.2K
Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
15:57

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle

Published on: July 11, 2015

12.8K

Related Experiment Videos

Last Updated: Mar 9, 2026

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.4K
Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

11.2K
Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
15:57

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle

Published on: July 11, 2015

12.8K

Area of Science:

  • Immunology
  • Vaccinology
  • Epidemiology

Background:

  • Pertussis remains a significant global vaccine-preventable disease.
  • Waning immunity post-vaccination contributes to increased pertussis prevalence in adults.
  • Differences in vaccine composition and schedules affect immune persistence.

Purpose of the Study:

  • To review immune persistence data following various pertussis vaccination strategies.
  • To compare findings across countries with differing vaccination approaches.
  • To discuss future directions for serological studies in pertussis.

Main Methods:

  • Literature review of studies on pertussis vaccine immune persistence.
  • Comparative analysis of vaccination strategies and their impact on immunity.
  • Synthesis of data on waning immunity and serological responses.

Main Results:

  • Immunity duration varies significantly between whole-cell and acellular pertussis vaccines.
  • Acellular pertussis vaccines may offer shorter protection duration compared to whole-cell vaccines.
  • Waning immunity is a key factor in the resurgence of pertussis in vaccinated populations.

Conclusions:

  • Sustained protection against pertussis requires ongoing strategies like booster doses or maternal immunization.
  • The World Health Organization emphasizes the need for robust booster programs when switching to acellular vaccines.
  • Further research into long-term immune persistence and serological markers is essential.